Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide
- 30 June 2005
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (6) , 770-778
- https://doi.org/10.1016/j.rmed.2004.10.024
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recurrent Exacerbations in Severe Asthma Are Associated with Enhanced Airway Closure During Stable EpisodesAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humansJournal of Allergy and Clinical Immunology, 1999
- Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate AsthmaChest, 1999
- Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEuropean Respiratory Journal, 1998
- Inflammatory Cell Distribution within and along Asthmatic AirwaysAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Improved delivery of inhaled steroids to the large and small airwaysRespiratory Medicine, 1998
- Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily doseRespiratory Medicine, 1998
- Inflammation of small airways in asthma☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Alveolar tissue inflammation in asthma.American Journal of Respiratory and Critical Care Medicine, 1996
- Airway structure and inflammatory cells in fatal attacks of asthmaEuropean Respiratory Journal, 1996